I can only assume it is due to management pointing to cash burn issues at the last results issues and some concern over a capital raise .... I bought a little today and will keep adding as we fall .... but it does feel a bit like a fools errand at the moment.
They have ploughed and continue to plough so much money in to IT systems you do start to wonder if it is money well spent .... Cognigram has been a complete waste of money up to this point .... millions and millions of dollars spent and then they effectively seem to have abandoned it. I also think they need to take a long and serious look at this co location of CEO .... 2 weeks in US / 2 weeks in Aus really does not seem to be working + it is expensive. The other thing that is annoying me is both the CEO and Chairman seem to have family members that work in the company ... I can almost accept it but then you have to be completely transparent in my view.... role / salary etc ..... it is just a footnote in the AR that they have conflicted interests. While I am at it I also think the fact that they had to restate the last 4C because the first one did not add up is unforgivable and somebody should have been fired for that.
Any hint of good news and we will explode to the upside .... but I am not holding my breath.
- Forums
- ASX - By Stock
- CGS
- Ann: Cogstate computerised tests part of FDA approved drug trial
CGS
cogstate ltd
Add to My Watchlist
0.61%
!
$1.66

Ann: Cogstate computerised tests part of FDA approved drug trial, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $280.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.68 | $1.62 | $34.96K | 21.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 621 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 2298 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 621 | 1.610 |
7 | 7699 | 1.600 |
1 | 3785 | 1.585 |
3 | 10722 | 1.575 |
1 | 829 | 1.570 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 2298 | 1 |
1.710 | 10000 | 1 |
1.740 | 1000 | 1 |
1.750 | 1758 | 1 |
1.790 | 1789 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online